graduation at Engenharia de Bioprocessos e Biotecnologia from Universidade Estadual Paulista Júlio de Mesquita Filho (2019) and master's at Biociências e Biotecnologia from Fiocruz - Instituto Carlos Chagas (2020). Has experience in Biotechnology, acting on the following subjects: nefropatia diabética, proteômica, diabetes mellitus, hipertensão and esi-ms/ms. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Post-translational modifications (PTMs) alter the physicochemical and biological properties of a protein, influencing its function in health and disease state. Indeed, PTMs regulate stability, degradation, enzymatic function, protein interaction, and subcellular localization. Protein arginylation is a PTM little-explored described for the first time in 1963. Only in 2002, a study showed t…
The world scenario is alarming about the incidence of diabetes mellitus, it is currently estimated that there are 382 million people worldwide with the pathology, and that by 2035 this number should reach 471 million. Diabetes mellitus type1 (DM1) is a chronic endocrine-metabolic disorder characterized by total or partial destruction the beta cells of the islets of pancreatic Langerhans, …
Amyotrophic lateral sclerosis (ALS) occurs due to the degeneration of both upper and lower motor neurons in the cerebral cortex and spinal cord. ALS has a prevalence of 5 individuals in 100,000 each year worldwide, most being classified as sporadic, therefore, of unknown cause, making it challenging to adopt palliative strategies. The causes of ALS are only partially understood; however, …
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID